Previous 10 | Next 10 |
BIOQUAL’s Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 6, 2023, payable on October 27, 2023. This is the twenty-second dividend declared by BIOQUAL. Statements herein that are not descriptions of historical facts are forward-lookin...
2023-09-20 16:40:34 ET More on BIOQUAL Dividend scorecard for BIOQUAL Financial information for BIOQUAL For further details see: BIOQUAL GAAP EPS of $0.93, revenue of $62.66M
BIOQUAL, Inc. (OTC Pink:BIOQ) www.bioqual.com : Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on thes...
2023-04-21 16:24:17 ET BIOQUAL press release ( OTCPK:BIOQ ): Q3 GAAP EPS of -$1.27. Revenue of $14.11M (-17.6% Y/Y). For further details see: BIOQUAL GAAP EPS of -$1.27, revenue of $14.11M
BIOQUAL, Inc. (OTC Pink:BIOQ) www.bioqual.com : For more detail related to the fiscal year 2023 unaudited third quarter results, please visit our web site at www.bioqual.com . Statements herein that are not descriptions of historical facts are forward-looking and subject to ...
BIOQUAL press release ( OTCPK:BIOQ ): FQ2 GAAP EPS of $1.45. Revenue of $16.68M (+9.7% Y/Y). For further details see: BIOQUAL GAAP EPS of $1.45, revenue of $16.68M
BIOQUAL, Inc. (OTC-Pink:BIOQ) ( www.bioqual.com ): For more detail related to the fiscal year 2023 unaudited second quarter results, please visit our web site at www.bioqual.com . Statements herein that are not descriptions of historical facts are forward-looking and subject t...
BIOQUAL, Inc., today announced that Dave Newcomer will retire from his role as Chief Financial Officer effective June 3, 2022. Mr. Newcomer will remain in his current position until then to support with the transition of his responsibilities to his successor. Additionally, on April 26, ...
BIOQUAL, Inc., Announces Creation of the Role of Chief Scientific Officer and Appointment of Hanne Andersen Elyard, PhD, As the Initial Chief Scientific Officer. In her role as Chief Scientific Officer, Dr. Elyard will oversee BIOQUAL’s in-vivo and in-vitro contract research ...
BIOQUAL press release (OTCPK:BIOQ): Q3 GAAP EPS of $0.96. Revenue of $17.13M (+36.2% Y/Y). For further details see: BIOQUAL GAAP EPS of $0.96, revenue of $17.13M
News, Short Squeeze, Breakout and More Instantly...
BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com : For more detail related to the fiscal year 2024 unaudited third quarter results, please visit our web site at www.bioqual.com . Statements herein that are not descriptions of historical facts are forward-looking and subjec...
Guardforce AI Co. Limited (GFAI) is expected to report for quarter end 2023-12-31 Bright Scholar Education Holdings Limited American Depositary Shares each representing four Class A (BEDU) is expected to report for quarter end 2024-02-29 Schlumberger N.V. (SLB) is expected to report $0.74...
BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com : For more detail related to the fiscal year 2024 unaudited second quarter results, please visit our web site at www.bioqual.com . Statements herein that are not descriptions of historical facts are forward-looking and subje...